ShareValue scores for 0243.KLSE: Valuation 39, Quality 55, Growth 39, Health 47.

0243.KLSE
Bursa Malaysia

Cengild Medical Berhad

MYR 0.20(+2.63%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 9%
Valuation
39
Overvalued
Price vs Value
Quality
55
Moderate
Business Strength
Growth
39
Weak
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
51
Neutral
Price Trend

Company Details

About

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery; and chemotherapy. It also provides medical management services; nursing services and clinical support services; clinical laboratory and pharmacy; operating theatre, endoscopy, radiology and imaging services; accident and emergency care, and health screenings; and consultant services. Cengild Medical Berhad was founded in 2017 and is based in Kuala Lumpur, Malaysia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026